Company Commits Revenue from Majority Interest in BONK.fun to Fuel Strategic Target of Owning 5% of Global Supply; Beverage Division to Reinvest for Growth
Read More
First Profitable Year Achieved with Record Revenue of $63.8M up 43% YoY; Adjusted EBITDA 1 of $8.8M, Up 115% YoY, and Net Profit of $3.3M ($0.09/share)
Strengthened Balance Sheet Through Strong Operational Performance, Equity Issuances and Expanded Financial Flexibility via new $25M BMO and $51M EXIM Facilities
New Product Launches in Robotics, GSE and Energy Storage; Jamestown Manufacturing Buildout Advancing; Commercial Shipments Expanding
Read MoreSMX's engagement with NAFRA spotlights increasing interest in systems that improve material efficiency and downstream certainty without altering existing infrastructure
Read More
More top doctors joined the region's leading physician-owned healthcare group in 2025, increasing patients' access to primary care and medical specialties including family medicine, cardiology, vascular surgery, pain management, rheumatology, and podiatry.
Read MoreConditional approval extended through December 2026 for the treatment of CID in dogs
CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA's June deadline - 51 dogs enrolled to date; ~49 more expected
The AI-native PeopleOS replaces fragmented HR stacks with a fully adaptive platform that lets organizations design, evolve, and run every people process their own way, keeping pace with a world that never stops changing
Read MoreCompany Projects Substantial Net Income Expansion Supported by Debt-Free Balance Sheet, ~ $4M Yerbaé Contribution, and Majority Revenue Interest in BONK.fun
Read MorePhysical goods orders increased by 30% year-over-year for the Two Months Ended November 30, 2025
Physical goods GMV increased by 35% year-over-year for the Two Months Ended November 30, 2025; excluding corporate sales, physical goods GMV grew 41% year-over-year
Nigeria continued to perform strongly for the Two Months Ended November 30, 2025, with physical goods orders up 28% and physical goods GMV up 45% year-over-year
With the global functional mushroom industry projected to surge past $22.3 billion by 2030, fueled by a 9.3%+ CAGR, FBCD's strategic acquisition positions the company at the forefront of one of the fastest-growing wellness sectors in America - especially as Oregon leads the nation in legalized therapeutic mushroom innovation.
Read More